Trimas (NASDAQ:TRS) has been upgraded from Neutral to Overweight in a statement by JPMorgan earlier today.
- Updated: September 27, 2016
JPMorgan has upgraded Trimas (NASDAQ:TRS) from Neutral to Overweight in a statement released on 09/27/2016.
On 7/20/2015, Jefferies & Co released a statement on Trimas (NASDAQ:TRS) dropped the target price from $32.00 to $26.00 that suggested an upside of 0.08%.
Having a price of $17.51, Trimas (NASDAQ:TRS) traded -1.68% lower on the day. With the last close down -1.99% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. TRS has recorded a 50-day average of $18.37 and a two hundred day average of $17.86. Trade Volume was up over the average, with 356,381 shares of TRS changing hands over the typical 219,164
Recent Performance Chart
Trimas has with a one year low of $14.76 and a one year high of $22.02 and has a market capitalization of $0.
General Company Details For Trimas (NASDAQ:TRS)
TriMas Corporation is a designer, manufacturer and distributor of engineered and applied products for commercial, industrial and consumer markets. The Company operates through four segments: Packaging, Aerospace, Energy and Engineered Components. The Packaging segment is a designer, manufacturer and distributor of engineered closure and dispensing systems for a range of end markets, including steel and plastic industrial, and consumer packaging applications. The Aerospace segment is a designer and manufacturer of a range of products for use in the aerospace industry. The Energy segment is a manufacturer and distributor of metallic and non-metallic gaskets, bolts, industrial fasteners and specialty products for the petroleum refining, petrochemical, oil field and industrial markets. The Engineered Components segment is a designer, manufacturer and distributor of high-pressure and acetylene cylinders for the transportation, storage and dispensing of compressed gases.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.